Gerd Assmann
Impact in
- Endocrinology, Diabetes and Metabolism top 0.05%
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Surgery top 0.05%
- Lipoproteins and Cardiovascular Health
- Cholesterol and Lipid Metabolism
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 162
- Surgery 221
- Lipoproteins and Cardiovascular Health 146
- Cholesterol and Lipid Metabolism 76
- Co-authors
- H. Schulte (100 shared papers)Arnold von Eckardstein (114 shared papers)Paul A Cullen (57 shared papers)Jerzy–Roch Nofer (42 shared papers)Harald Funke (93 shared papers)Udo Seedorf (52 shared papers)Gerd Schmitz (22 shared papers)Manfred Fobker (20 shared papers)
- Journals
- Atherosclerosis (23 papers)Arteriosclerosis Thrombosis and Vascular Biology (23 papers)Journal of Lipid Research (21 papers)Journal of Biological Chemistry (19 papers)Clinical Chemistry and Laboratory Medicine (CCLM) (19 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Gerd Assmann
509 papers receiving 34.7k citations
Gerd Assmann's Hit Papers
Peers
Comparison fields: 5 of 180
- Endocrinology, Diabetes and Metabolism 9.5k
- Surgery 13.4k
- Cardiology and Cardiovascular Medicine 6.4k
- Cancer Research 3.9k
- Biochemistry 1.5k
Countries citing papers authored by Gerd Assmann
This map shows the geographic impact of Gerd Assmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerd Assmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerd Assmann more than expected).
Fields of papers citing papers by Gerd Assmann
This network shows the impact of papers produced by Gerd Assmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerd Assmann. The network helps show where Gerd Assmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Gerd Assmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 518 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | From Vulnerable Plaque to Vulnerable Patient Hit paper breakdown → | 2003 | 2267 |
| 2 | From Vulnerable Plaque to Vulnerable Patient Hit paper breakdown → | 2003 | 1944 |
| 3 | Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1 Hit paper breakdown → | 1999 | 1257 |
| 4 | Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular Munster (PROCAM) Study Hit paper breakdown → | 2002 | 1200 |
| 5 | World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions Hit paper breakdown → | 2019 | 836 |
| 6 | Association of Cardiometabolic Multimorbidity With Mortality Hit paper breakdown → | 2015 | 820 |
| 7 | High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport Hit paper breakdown → | 1996 | 587 |
| 8 | 2001 | 582 | |
| 9 | A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease Hit paper breakdown → | 2011 | 579 |
| 10 | 2004 | 566 | |
| 11 | 2004 | 536 | |
| 12 | 2004 | 523 | |
| 13 | 2002 | 496 | |
| 14 | Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men. Hit paper breakdown → | 1994 | 485 |
| 15 | 1996 | 395 | |
| 16 | 2008 | 393 | |
| 17 | 1997 | 376 | |
| 18 | 1990 | 371 | |
| 19 | 1983 | 351 | |
| 20 | 1988 | 348 |
About Gerd Assmann
Gerd Assmann is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Cancer Research, Cardiology and Cardiovascular Medicine and Molecular Biology, having authored 518 papers that have together received 36.8k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (162 papers), Lipoproteins and Cardiovascular Health (146 papers), Cholesterol and Lipid Metabolism (76 papers), Cancer, Lipids, and Metabolism (70 papers), Peroxisome Proliferator-Activated Receptors (39 papers), Lipid metabolism and disorders (37 papers), Blood properties and coagulation (30 papers) and Drug Transport and Resistance Mechanisms (26 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (9.5k citations), Surgery (13.4k citations), Cardiology and Cardiovascular Medicine (6.4k citations), Cancer Research (3.9k citations) and Biochemistry (1.5k citations). Gerd Assmann has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include H. Schulte, Arnold von Eckardstein, Paul A Cullen, Jerzy–Roch Nofer, Harald Funke, Udo Seedorf, Gerd Schmitz, Manfred Fobker, Stephan Rust and Yadong Huang. Their work appears in journals such as Atherosclerosis, Arteriosclerosis Thrombosis and Vascular Biology, Journal of Lipid Research, Journal of Biological Chemistry and Clinical Chemistry and Laboratory Medicine (CCLM).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.